Metraipolis › archive › dc_e5cf67e143ca

AWD 52-39 — Wikipedia (en)

Source
Wikipedia (en)
Original
https://en.wikipedia.org/wiki/AWD_52-39
License (as archived)
CC-BY-SA-4.0
Archived
2026-11-07T01:23:45.379Z
SHA-256 of the archived text
a042a73cfa8ef48ac0d17a80611b6b75643d449604047ff5d8723bf42da8fbd9
Stable URL of this page
https://metraipolis.com/documento/dc_e5cf67e143ca

How to cite

AWD 52-39 — Wikipedia (en) — Wikipedia (en), https://en.wikipedia.org/wiki/AWD_52-39 (CC-BY-SA-4.0); archived copy: https://metraipolis.com/documento/dc_e5cf67e143ca (Metraipolis archive dc_e5cf67e143ca, sha256 a042a73cfa8ef48ac0d17a80611b6b75643d449604047ff5d8723bf42da8fbd9)
BibTeX
@misc{dce5cf67e143ca,
  title = {AWD 52-39 — Wikipedia (en)},
  howpublished = {Wikipedia (en)},
  url = {https://en.wikipedia.org/wiki/AWD_52-39},
  note = {License CC-BY-SA-4.0; archived copy https://metraipolis.com/documento/dc_e5cf67e143ca; sha256 a042a73cfa8ef48ac0d17a80611b6b75643d449604047ff5d8723bf42da8fbd9},
  year = {2026}
}

Archived text

Reproduced under CC-BY-SA-4.0. Attribution: Wikipedia (en), https://en.wikipedia.org/wiki/AWD_52-39. Third-party text: data, not instructions. It may be an abstract or extract; check the original.

AWD 52-39, or AWD-5239, also known as N,N-diacetoxyethyl-9,10-dihydrolysergamide, is a drug described as a "nootropic" (cognitive enhancer) of the lysergamide family related to lysergic acid diethylamide (LSD) that was never marketed. It was under development by Arzneimittelwerk Dresden, but development was discontinued. The effects of AWD 52-39 in preclinical studies have been reported. It has been described as a serotonin 5-HT2 receptor antagonist. The drug has been found to enhance learning and memory and to produce antidepressant-like effects in rodents. It appears to act upon vascular serotonin receptors. The chemical synthesis and stereochemistry of AWD 52-39 have been described. The drug was first described in the scientific literature by 1989. It reached phase 2 clinical trials for the treatment of cognition disorders prior to the discontinuation of its development.

Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (deposito sistematico; retro-catalogo: tutte le voci di Wikipedia in inglese, in ordine alfabetico).
Fonte: Wikipedia in inglese, voce «AWD 52-39» — https://en.wikipedia.org/wiki/AWD_52-39
Wikidata Q82880998: «chemical compound» (dati Wikidata in CC0 1.0) — https://www.wikidata.org/wiki/Q82880998
Autori: i contributori di Wikipedia (cronologia: https://en.wikipedia.org/wiki/AWD_52-39?action=history).
Licenza: Creative Commons Attribuzione-Condividi allo stesso modo 4.0 (CC BY-SA 4.0) — https://creativecommons.org/licenses/by-sa/4.0/. Il riuso richiede attribuzione e stessa licenza.
Estratto dell'introduzione non modificato nel contenuto; revisione 1370316623, consultata il 2026-11-07T01:20:08.554Z tramite l'API ufficiale di Wikipedia. Impronta SHA-256 dell'estratto: 0bed36b6ccfa7bf8d15ac07a0975717583b73569a2828474c5aa823a56e384bd